These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 12754254

  • 1. Sorcin regulates excitation-contraction coupling in the heart.
    Meyers MB, Fischer A, Sun YJ, Lopes CM, Rohacs T, Nakamura TY, Zhou YY, Lee PC, Altschuld RA, McCune SA, Coetzee WA, Fishman GI.
    J Biol Chem; 2003 Aug 01; 278(31):28865-71. PubMed ID: 12754254
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling.
    Takeda T, Asahi M, Yamaguchi O, Hikoso S, Nakayama H, Kusakari Y, Kawai M, Hongo K, Higuchi Y, Kashiwase K, Watanabe T, Taniike M, Nakai A, Nishida K, Kurihara S, Donoviel DB, Bernstein A, Tomita T, Iwatsubo T, Hori M, Otsu K.
    FASEB J; 2005 Dec 01; 19(14):2069-71. PubMed ID: 16204356
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regulation of cardiac excitation-contraction coupling by sorcin, a novel modulator of ryanodine receptors.
    Farrell EF, Antaramian A, Benkusky N, Zhu X, Rueda A, Gómez AM, Valdivia HH.
    Biol Res; 2004 Dec 01; 37(4):609-12. PubMed ID: 15709688
    [Abstract] [Full Text] [Related]

  • 6. Effects of adenovirus-mediated sorcin overexpression on excitation-contraction coupling in isolated rabbit cardiomyocytes.
    Seidler T, Miller SL, Loughrey CM, Kania A, Burow A, Kettlewell S, Teucher N, Wagner S, Kögler H, Meyers MB, Hasenfuss G, Smith GL.
    Circ Res; 2003 Jul 25; 93(2):132-9. PubMed ID: 12805242
    [Abstract] [Full Text] [Related]

  • 7. Association of sorcin with the cardiac ryanodine receptor.
    Meyers MB, Pickel VM, Sheu SS, Sharma VK, Scotto KW, Fishman GI.
    J Biol Chem; 1995 Nov 03; 270(44):26411-8. PubMed ID: 7592856
    [Abstract] [Full Text] [Related]

  • 8. Sorcin interacts with sarcoplasmic reticulum Ca(2+)-ATPase and modulates excitation-contraction coupling in the heart.
    Matsumoto T, Hisamatsu Y, Ohkusa T, Inoue N, Sato T, Suzuki S, Ikeda Y, Matsuzaki M.
    Basic Res Cardiol; 2005 May 03; 100(3):250-62. PubMed ID: 15754088
    [Abstract] [Full Text] [Related]

  • 9. Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels.
    Meyers MB, Puri TS, Chien AJ, Gao T, Hsu PH, Hosey MM, Fishman GI.
    J Biol Chem; 1998 Jul 24; 273(30):18930-5. PubMed ID: 9668070
    [Abstract] [Full Text] [Related]

  • 10. miR-1 mediated suppression of Sorcin regulates myocardial contractility through modulation of Ca2+ signaling.
    Ali R, Huang Y, Maher SE, Kim RW, Giordano FJ, Tellides G, Geirsson A.
    J Mol Cell Cardiol; 2012 May 24; 52(5):1027-37. PubMed ID: 22326846
    [Abstract] [Full Text] [Related]

  • 11. Transgenic overexpression of the Ca2+-binding protein S100A1 in the heart leads to increased in vivo myocardial contractile performance.
    Most P, Remppis A, Pleger ST, Löffler E, Ehlermann P, Bernotat J, Kleuss C, Heierhorst J, Ruiz P, Witt H, Karczewski P, Mao L, Rockman HA, Duncan SJ, Katus HA, Koch WJ.
    J Biol Chem; 2003 Sep 05; 278(36):33809-17. PubMed ID: 12777394
    [Abstract] [Full Text] [Related]

  • 12. In vivo adenoviral transfer of sorcin reverses cardiac contractile abnormalities of diabetic cardiomyopathy.
    Suarez J, Belke DD, Gloss B, Dieterle T, McDonough PM, Kim YK, Brunton LL, Dillmann WH.
    Am J Physiol Heart Circ Physiol; 2004 Jan 05; 286(1):H68-75. PubMed ID: 12958030
    [Abstract] [Full Text] [Related]

  • 13. Sorcin ablation plus β-adrenergic stimulation generate an arrhythmogenic substrate in mouse ventricular myocytes.
    Chen X, Weber C, Farrell ET, Alvarado FJ, Zhao YT, Gómez AM, Valdivia HH.
    J Mol Cell Cardiol; 2018 Jan 05; 114():199-210. PubMed ID: 29174767
    [Abstract] [Full Text] [Related]

  • 14. Enhanced calcium cycling and contractile function in transgenic hearts expressing constitutively active G alpha o* protein.
    Zhu M, Gach AA, Liu G, Xu X, Lim CC, Zhang JX, Mao L, Chuprun K, Koch WJ, Liao R, Koren G, Blaxall BC, Mende U.
    Am J Physiol Heart Circ Physiol; 2008 Mar 05; 294(3):H1335-47. PubMed ID: 18192223
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of [Ca2+]i transient decrease in cardiomyopathy of db/db type 2 diabetic mice.
    Pereira L, Matthes J, Schuster I, Valdivia HH, Herzig S, Richard S, Gómez AM.
    Diabetes; 2006 Mar 05; 55(3):608-15. PubMed ID: 16505222
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Constitutive beta2-adrenergic signalling enhances sarcoplasmic reticulum Ca2+ cycling to augment contraction in mouse heart.
    Zhou YY, Song LS, Lakatta EG, Xiao RP, Cheng H.
    J Physiol; 1999 Dec 01; 521 Pt 2(Pt 2):351-61. PubMed ID: 10581307
    [Abstract] [Full Text] [Related]

  • 19. Interaction of calcium/calmodulin-dependent protein kinase IIdeltaC with sorcin indirectly modulates ryanodine receptor function in cardiac myocytes.
    Anthony DF, Beattie J, Paul A, Currie S.
    J Mol Cell Cardiol; 2007 Oct 01; 43(4):492-503. PubMed ID: 17707398
    [Abstract] [Full Text] [Related]

  • 20. Calcium-sensitivity of the SR calcium release channel in failing and nonfailing human myocardium.
    Schotten U, Schumacher C, Conrads V, Braun V, Schöndube F, Voss M, Hanrath P.
    Basic Res Cardiol; 1999 Jun 01; 94(3):145-51. PubMed ID: 10424232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.